Epilepsy and Alcohol: Triggers and Safe Drinking

Alcohol withdrawal seizures may begin within hours to days of stopping alcohol use or starting an alcohol detox. The timeframe will be different for everyone, but seizures will normally start within the first 72 hours. If someone has a seizure from alcohol withdrawal symptoms, you should move things out of the way that they could accidentally hurt themselves with during the seizure. You should also call 911 and get emergency medical help as soon as possible, even if the seizure has stopped.

alcoholic seizures treatment

The seizure type is predominantly the generalized tonic-clonic, occurring singly in about 50% of cases or occurring as a series of seizures within a 6-hour period (68). In principle, patients have a nonfocal neurologic examination and alcohol blood levels must be close to zero g/dL. Other causes of acute symptomatic seizures must be ruled out (see Differential diagnosis), especially if seizures are focal or if status epilepticus develops (45). Phenytoin is not effective in preventing or treating alcohol withdrawal seizures. Seizures due to alcohol withdrawal are best prevented and treated with benzodiazepines. The peak period of risk for an alcohol withdrawal seizure is between 1 and 2 days after the last drink.

Substance Abuse Treatment

According to a 2017 study, the use of the Objective Alcohol Withdrawal Scale (OAWS) was more useful for treatment because it can be used as a framework and tailored to individual cases. (1) Chronic intake of ethanol alters fluidity of lipid cell membranes in the brain, affecting interactions between proteins and membrane phospholipids. These changes https://ecosoberhouse.com/ perturb physiologic function and signal transduction of NMDA, GABA-A, and L-type calcium receptors. It is hypothesized that these changes explain tolerance to alcohol and predispose to a hyperexcitable state when alcohol is withdrawn. • It is characterized by being generalized tonic-clonic, and patients have a nonfocal neurologic examination.

When patients present repeatedly with typical alcohol withdrawal seizures, imaging is not necessary unless changes in seizure type and frequency, seizure occurrence more than 48 hours after cessation of drinking, or other unusual features are present. Benzodiazepine medications are the first line treatment  for alcohol withdrawal seizures.[6] Benzodiazepines are controlled substances and usually need to be carefully monitored, particularly at the necessary high doses to prevent withdrawal seizures. These medications can be given orally or intravenously, and can be dosed as needed or even scheduled/around the clock, depending on the patient’s needs and the severity of their symptoms.

What does an alcohol withdrawal seizure feel like?

This literature review was subject to publication bias as positive studies are more likely to be published than negative studies. The authors attempted to control for publication bias by also examining and reporting on current studies on clinicaltrials.gov. Future randomized controlled studies are needed to expand on the promising findings from the many open-label reports and to better understand the real-world efficacy of these pharmacotherapies. Preliminary studies have suggested that the newer anticonvulsants topiramate and zonisamide may treat AWS. Topiramate was administered in a fixed dose of 25 mg every 6 h (100 mg/day), and symptom-triggered diazepam was provided for rescue if study medications failed to suppress acute withdrawal symptoms.

Although patients with ARS rarely enter status epilepticus (SE), alcohol withdrawal is a common contributing factor in many cases of SE. Evaluation involves searching for a focal cause of the seizure as well as looking for comorbid conditions, including delirium tremens, that may complicate the management alcohol withdrawal seizure of chronic alcohol abusers. Treatment of ARS is similar to general management of alcohol withdrawal, with benzodiazepines being the mainstay of treatment. Treatment of alcohol-related SE is similar to that of other causes of SE. Phenytoin is not indicated for treatment of ARS unless the patient enters SE.

Alcohol withdrawal

This results in the requirement of increasingly larger doses of ethanol to achieve the same euphoric effect, a phenomenon known as tolerance. Alcohol acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, thereby reducing the CNS excitatory tone. Chronic use of alcohol leads to an increase in the number of NMDA receptors (up regulation) and production of more glutamate to maintain CNS homeostasis [Figure 1c]. Free by the Sea is a treatment facility located in the state of Washington on 5 acres of waterfront property. We have professional relationships with detox centers in the surrounding area. After detox, our serene setting and our staff of experienced, compassionate professionals can offer you the rest and rehab that you so desperately need and deserve.

Someone with epilepsy should use alcohol very carefully, as it can increase the risk of serious health problems and complications. The use of alcohol to prevent or treat alcohol withdrawal and DTs is not recommended. Alcohol has multiple toxicities, including pancreatitis, hepatitis, cardiomyopathy, gastritis, and bone marrow suppression. It also has a short half-life and requires monitoring of blood levels when used intravenously, and its use may make it appear to the patient with alcoholism who is beginning recovery that alcohol intake is being condoned. Alcohol treatment has not been shown in controlled trials to be effective in preventing seizures or DTs. According to a 2017 article, alcohol withdrawal seizures in those without epilepsy may occur 6–48 hours after a person consumes their last alcoholic drink.

What to Do If a Friend or Loved One Has an Alcohol-Related Seizure

In people with epilepsy, drinking three or more drinks may increase the risk of seizures. Heavy drinking, particularly withdrawal from heavy drinking, may trigger seizures in those with epilepsy. Alcohol may also affect anti-seizure medications, which could trigger seizures. In a symptom-triggered regimen, medication is given only when the CIWA-Ar score is higher than 8 points. Minor withdrawal symptoms can occur while the patient still has a measurable blood alcohol level.

Alcohol acts on receptors in the brain called gamma-aminobutyric acid, or GABA receptors, which are closely linked to seizure risk. If you or a loved one has a history of seizures or alcohol withdrawal, learning about the link between drinking and seizures is important. First, anyone with a history of alcohol withdrawal seizures should not attempt to stop alcohol use acutely, but should always seek medical help and supervision because of the high association of alcohol withdrawal seizures and high mortality. Screening patients for alcohol misuse can be eye-opening and beneficial for some patients in changing their drinking habits before any complications such as alcohol withdrawal syndrome (AWS) arise. Assessing patients in this way allows clinicians to provide counseling to those who engage in risky drinking patterns. Thyrotoxicosis, anticholinergic drug poisoning, and amphetamine or cocaine use can result in signs of increased sympathetic activity and altered mental status.

Gabapentin and carbamazepine appear to be the most promising NBAC agents for treating AWS, primarily as an adjunctive treatment to traditional benzodiazepines and/or in mild-to-moderate withdrawal of low-risk patients in outpatient settings. The evidence for use of NBACs to target heavy drinking in outpatient settings is stronger than the evidence for AWS, with most evidence being in support of topiramate and gabapentin. Pregabalin, an anticonvulsant that has been approved in Europe for treatment of generalized anxiety disorder, has also been studied for relapse prevention/harm reduction in AUDs. In an initial open-label 16-week trial of pregabalin (150–450 mg/day), ten of 20 patients receiving pregabalin remained alcohol-free at the end of the study—five relapsed, four dropped out, and one discontinued due to adverse effects. Pregabalin has also been compared head-to-head with naltrexone, which revealed similar efficacy on drinking-related outcomes in 71 recently detoxified alcohol-dependent subjects [91]. Unlike naltrexone, pregabalin improved anxiety, hostility, and psychoticism in vulnerable alcohol-dependent subjects, which suggests that pregabalin may be particularly helpful in select dual diagnosis patients.

The differences between these programs are the amount of time spent at the treatment facility, from 7 days per week to just a few hours a day for a few days per week. Complications can occur at any point during withdrawal (e.g., upon presentation) and often necessitate escalation of the level of care (e.g., specialist or critical care consultation and high-dose pharmacotherapy). Laboratory findings in AWS are usually attributable to chronic alcohol use disorder and tend to be mild. Withdrawal seizures may occur without prior significant features of AWS and may be the presenting symptom in some patients.

He received his Certificate in General Psychology from the American Board of Psychology and Neurology in 2002. Patients live at the facility for a totally immersive, structured experience. Suddenly stopping exposure to alcohol results in the brain being easily roused into a state of excitability or irritability (brain hyperexcitability). This is due to the receptors that were being obstructed by alcohol no longer being obstructed. If you decide to get treatment, your doctor can recommend the type of care that you need. Symptoms of AWS are often treated with sedatives called benzodiazepines.

  • While the reason for this is not fully understood, alcohol does create changes in receptors in your brain that affect your likelihood of having a seizure.
  • With AWS, you may experience a combination of physical and emotional symptoms, from mild anxiety and fatigue to nausea.
  • When a seizure nears 5 minutes in duration, it becomes a medical emergency.